Coloplast A/S (CLPBY)
12.56
+0.20
(+1.62%)
USD |
OTCM |
May 17, 16:00
Coloplast Shareholders Equity (Quarterly): 2.343B for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 2.343B |
December 31, 2023 | 2.246B |
September 30, 2023 | 2.450B |
June 30, 2023 | 947.08M |
March 31, 2023 | 1.030B |
December 31, 2022 | 849.89M |
September 30, 2022 | 1.096B |
June 30, 2022 | 1.021B |
March 31, 2022 | 1.091B |
December 31, 2021 | 977.20M |
September 30, 2021 | 1.274B |
June 30, 2021 | 1.109B |
March 31, 2021 | 1.093B |
December 31, 2020 | 953.69M |
September 30, 2020 | 1.168B |
June 30, 2020 | 959.74M |
March 31, 2020 | 972.66M |
December 31, 2019 | 817.22M |
September 30, 2019 | 1.013B |
June 30, 2019 | 904.77M |
March 31, 2019 | 927.68M |
December 31, 2018 | 795.36M |
September 30, 2018 | 998.58M |
June 30, 2018 | 806.93M |
March 31, 2018 | 888.76M |
Date | Value |
---|---|
December 31, 2017 | 759.18M |
September 30, 2017 | 942.08M |
June 30, 2017 | 762.69M |
March 31, 2017 | 727.44M |
December 31, 2016 | 599.27M |
September 30, 2016 | 762.73M |
June 30, 2016 | 672.69M |
March 31, 2016 | 748.49M |
December 31, 2015 | 589.73M |
September 30, 2015 | 709.85M |
June 30, 2015 | 870.86M |
March 31, 2015 | 938.39M |
December 31, 2014 | 880.84M |
September 30, 2014 | 1.071B |
June 30, 2014 | 992.14M |
March 31, 2014 | 1.077B |
December 31, 2013 | 1.127B |
September 30, 2013 | 1.225B |
June 30, 2013 | 1.075B |
March 31, 2013 | 1.091B |
December 31, 2012 | 1.049B |
September 30, 2012 | 1.046B |
June 30, 2012 | 903.41M |
March 31, 2012 | 889.02M |
December 31, 2011 | 773.71M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
817.22M
Minimum
Dec 2019
2.450B
Maximum
Sep 2023
1.216B
Average
1.026B
Median
Shareholders Equity (Quarterly) Benchmarks
Genmab A/S | 4.701B |
Ascendis Pharma A/S | -257.21M |
Galecto Inc | 28.16M |
Evaxion Biotech AS | -4.739M |
IO Biotech Inc | 115.47M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 6.964B |
Total Liabilities (Quarterly) | 4.620B |
Debt to Equity Ratio | 1.449 |
Current Ratio | 0.6005 |
Net Debt Paydown Yield | -0.21% |